TAUNS Laboratories (197A) · InitiativeAdvanced
Expansion of Sales Channels Through Collaboration with Sales Representatives, Agencies and Pharmaceutical Companies
First written in FY2024. 4 of 5 entries say "Advanced", first in 2026-05-14. Latest entry: FY2026.
5entries
3years
3from disclosures
How it moved
Same theme, other companies
Expanding and deepening the network of sales partners and business alliancesA theme 131 companies write about · 1 as a headwind · 148 as a tailwind
72 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 131 companies compared. The sentences above are computed from all 131.Full recordFilings, disclosures and news, newest first
- FY2026AdvancedAnnual report
「We will also promote the adoption of new testing methods through partnerships with major testing centers.」
In addition to collaboration with sales representatives, major wholesalers and pharmaceutical companies, the company identified partnerships with major testing centers as a new sales and adoption channel. - FY2024First statedAnnual report
「Going forward, we will focus on building and strengthening relationships with new and existing medical institutions by further expanding our workforce. At the same time, because there are medical institutions we have not yet been able to reach, we are working to expand our sales channels by strengthening relationships with key distributors that handle our products and promoting joint sales with pharmaceutical companies.」
As of 30 June 2024, the company had 35 sales representatives, more than 60% of whom had over 10 years of industry experience.